Moreover, with very little market penetration, & in ONLY the U.S., the price is EXTREMELY UNDERVALUED. So with the hit piece FDA petition COORDINATED with a bogus attempt at a class action I bought 2,500 shares of SAVA pre-market low $80 & change & then some at market open.
I'd like to see more progress here before I do likewise... But I also think SAVA has the larger market overall, plus the blood test will be worth the CURRENT Market Cap if these final hurdles go as expected.
The NOVEL APPROACH to solving the problem, versus every other lab is what sold me. GLA